FINANCIALS

PTGX Protagonist Therapeutics Inc 1377121

Income Statement
Revenue	ptgx-20240930x10q	4,675,000
Net Income	ptgx-20240930x10q	-33,210,000
Profit Margin		-710.37%

Balance Sheet
Current Assets	476,769,000
Assets	603,857,000
Current Liabilities	44,578,000
Liabilities	71,942,000
Equity	531,915,000
Shares Out	58,905,000

Cash Flow Statement
Operating Cash Flow	213,330,000
Investing Cash Flow	-290,758,000

Market Analysis
Market Cap	2,680,158,845
Price	36.82
BVPS	9.03
PB	4.09
EPS	2.64
PE	17.25
PS	143.32
FCF	-77,428,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view PTGX documents filed with the SEC.

PTGX Filings Clear

View A List of Tickers